"Insulin, Regular, Human" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Regular insulin preparations that contain the HUMAN insulin peptide sequence.
| Descriptor ID |
D061386
|
| MeSH Number(s) |
D06.472.699.587.200.500.625.500 D12.644.548.586.200.500.625.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Insulin, Regular, Human".
Below are MeSH descriptors whose meaning is more specific than "Insulin, Regular, Human".
This graph shows the total number of publications written about "Insulin, Regular, Human" by people in this website by year, and whether "Insulin, Regular, Human" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2022 | 0 | 6 | 6 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Insulin, Regular, Human" by people in Profiles.
-
Increased Plasma Branched Short-Chain Fatty Acids and Improved Glucose Homeostasis: The Microbiome and Insulin Longitudinal Evaluation Study (MILES). Diabetes. 2024 Mar 01; 73(3):385-390.
-
The Rare and Atypical Diabetes Network (RADIANT) Study: Design and Early Results. Diabetes Care. 2023 06 01; 46(6):1265-1270.
-
Response to Comment on Pietropaolo et al. Incidence of an Insulin-Requiring Hyperglycemic Syndrome in SARS-CoV-2- Infected Young Individuals: Is It Type 1 Diabetes? Diabetes 2022;71:2656-2663. Diabetes. 2022 12 01; 71(12):e19.
-
Incidence of an Insulin-Requiring Hyperglycemic Syndrome in SARS-CoV-2-Infected Young Individuals: Is It Type 1 Diabetes? Diabetes. 2022 12 01; 71(12):2656-2663.
-
Butyrate-Producing Bacteria and Insulin Homeostasis: The Microbiome and Insulin Longitudinal Evaluation Study (MILES). Diabetes. 2022 11 01; 71(11):2438-2446.
-
Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical Trial. Diabetes Care. 2022 08 01; 45(8):1907-1910.
-
Comparison of Bayesian vs Frequentist Adaptive Trial Design in the Stroke Hyperglycemia Insulin Network Effort Trial. JAMA Netw Open. 2022 05 02; 5(5):e2211616.
-
Adrenomedullin and its receptors are expressed in mouse pancreatic ?-cells and suppresses insulin synthesis and secretion. PLoS One. 2022; 17(3):e0265890.